Currently, the stock price of Enlivex Therapeutics Ltd (ENLV) is $1.25. In the most recent trading session, the stock underwent a significant upswing, peaking at $13.0 after opening at $1.25. The stock touched a low of $7.0 before closing at $1.82.
Enlivex Therapeutics Ltd’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $2.10 on 08/15/25, and the lowest price during that time was $0.81, recorded on 11/21/24.
52-week price history of ENLV Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Enlivex Therapeutics Ltd’s current trading price is -40.48% away from its 52-week high, while its distance from the 52-week low is 54.30%. The stock’s price range during this period has fluctuated between $0.81 and $2.10. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 10.36 million for the day, which was evidently higher than the average daily volume of 0.24 million over the last three months.
Financial Performance and Market Capitalization
Enlivex Therapeutics Ltd (ENLV) has experienced a quarterly rise of 25.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.81M and boasts a workforce of 36 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1072, with a change in price of +0.1600. Similarly, Enlivex Therapeutics Ltd recorded 277,224 in trading volume during the last 100 days, posting a change of +14.68%.
ENLV Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ENLV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
ENLV Stock Stochastic Average
The raw stochastic average for Enlivex Therapeutics Ltd over the last 50 days is presently at 29.17%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 13.27%. Further, the company’s Stochastic %K and %D values for the last 20 days were 58.79% and 71.98%, respectively.
ENLV Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 1.63%. However, over the past six months, we’ve seen a weaker performance of 19.05%. The price of ENLV fallen by 5.04% over the last 30 days. And in the last five days, it has fallen by -14.97%.
